New Jersey Archive » September, 2007

New Jersey - September, 2007

105 articles

• Canada Upholds Viagra Patent Over Apotex' Protests
• BMS, Apothecon Pay $515M To Settle Pricing Claims
• Tyco Shareholders Balk At $600M Attorneys' Fee
• Katun Fires Back In Antitrust Spat With Ricoh
• Orthopedic Cos. Pay $311M To End Kickback Probe
• Teva, Barr Win Transfer Of Aventis' Allegra Patent Suit
• Samsung Seeks To Stay Deleted Data Production
• Congress, Courts Wrestle With Contractor Definition
• Adams Respiratory Sues Perrigo Over Mucinex Patent
• Verizon Workers Parry Objections To A Quick Appeal
• Marcal Urges Court To Approve Settlement With EPA
• Damages Back In Play In Pfizer Patent Suit
• Pharmacogenomics And The "Learned Intermediary"
• Punitive Damages Nixed In Accutane Suicide Case
• Novartis Accused Of Forum Shopping In Lamisil Case
• LTL Shipment Industry Hit With Fuel Surcharge Suit
• Lawyers See Weather Vanes On High Court's Docket
• Roche Fights To Protect Boniva Patent
• Hedge Fund May Appeal KPMG Dismissal
• Insurance Broker Willis Sues Lawyer Over Liability
• Rep. Accuses Bush of Thwarting Calif. EPA Waiver
• Dr. Reddy's Wants Clarinex Claims Trimmed
• Barr Sued Over Chewable Contraceptive
• U.S. Wants Court Approval Of Marcal's Superfund Deal
• Dutch Pension Fund Files Amended Suit Over Vioxx
• Parties Seek Stay In Pet Food MDL Pending Mediation
• PSEG, Verizon To Pay $306K To Settle Flood Suit
• Pfizer Wins Appeal Over Neurontin
• AWP Counsel Asks Court To Kick Haviland Law Firm
• Verizon Balks At Judgment In Employee Class Action
• Novartis Drops Patent Claims Against Ranbaxy
• FDA Defends Delays Over Vioxx Documents
• Ford Asks For Mass Tort Designation Of Landfill Suits
• N.J. Law Irrelevant In Race Case V. Sears: EEOC
• Accutane Trial To Begin Monday, As Planned
• Ninth Circuit Breathes New Life Into W.R. Grace Case
• Seismic Shifts In Antitrust Law
• Actavis Claims Cancer Drug Patents Are Invalid
• Papers Sealed In Cigna Case Over Eating Disorders
• Epstein Becker
• Workers Say Metlife Forced Them To Pay Expenses
• Analysts Say Overstock Suit Threatens Free Speech
• Plaintiff Wants Out Of Insurer Kickbacks MDL Suit
• Q&A With Jackson Lewis' Vincent Cino
• Judge Schedules Hearing On Dana Cleanup Costs
• AIG Sued For Allegedly Misclassifying Employees
• ERISA Dispute Heats Up Insurer Kickbacks Suit
• Q&A With Nixon Peabody's Victor Milione
• California Passes Cloned Food Labeling Bill
• Honeywell Claims City Should Pay For Cleanup
• Plaintiffs Seek More Info In Enviga Case
• United Settles More 9/11 Passenger Cases
• Cordis Stent Case May Be Consolidated
• PSEG, Katz Trade Briefs In Dismissal Spat
• Roche Files Third Suit This Month Over Boniva ANDAs
• U.S. Attorney Fights Dana Over Superfund Claims
• Certified Ortho-McNeil FLSA Class Expected To Swell
• IP Attorney's Age Bias Suit Is Baseless: Law Firm
• Lerach To Plead Guilty, Could Face Jailtime: Report
• Aredia Case Belongs In State Court: Magistrate Judge
• Menu Foods Looks To Settle Pet Food MDL
• NuvaRing Plaintiffs Battle Organon Over Jurisdiction
• Orion sues Wockhardt Over Parkinson's Drug
• Sandata Assails 'Preposterous' Bid For Sanctions
• Sanofi Plaintiffs Challenge Employee Declarations
• 211 Plaintiffs Will Join Suit Against Merck Over FLSA
• Sans Injunction, Open Season For Generic Protonix
• Court Approves Kara Homes' Reorganization Plan
• Firms Fight For Top Dog Status In Pet Food Litigation
• Novo Nordisk Seeks To Halt Sanofi Insulin Pen
• Judge Orders Honeywell To Give Up Documents
• Teva, Dr. Reddy's Settle Generic Zoloft Dispute
• Judge Tosses Some Claims In Merck Race Bias Suit
• Airborne Suit Moved To Federal Court
• No Jurisdiction, No Standing, No Service: De Beers
• Hoffman-La Roche Sues Teva Over Osteoporosis Drug
• Rambus Seeks More Data On Destroyed E-Mails
• DOJ Wants Time In Dana Superfund Liability Dispute
• Becton, RTI Spar Over Syringe Patents, Competition
• Pioneer Claims Patent Misconduct By Samsung
• Judge Blocks Sale Of Teva's Generic Famvir
• Kara Homes Settles With Bond Companies
• 1st Amendment Bars Ratings-Based Claims: Moody's
• Eli Lilly Adds 9 Defendants To Strattera Suit
• Par Calls Novartis' Lotrel Patent Unenforceable
• Nationwide Class For Vioxx Suit Rejected
• Samsung, Rambus Joust Over Destroyed E-Mails
• Novartis Rebuffs Claims In Aredia Case
• Judge Allows Teva To Launch Generic Herpes Drug
• DuPont Clashes With Workers Over Benefits
• Third Circuit Revives Broadcom's Claims
• Schering, Employees To Face Off Over Benefit Plan
• Wal-Mart Tries To Keep Documents Off-Limits
• Judge OKs $28M Insurance Suit Settlement
• Ortho-McNeil Spars With Makers Of Ultracet Generic
• Gender Identity And Expression: The Next Frontier
• Brokers Score In Antitrust Conspiracy Class Action
• Home Depot Denies Negligence In Ladder Suit
• Appeals Court Throws Out Suit Against Elevator Cos.
• More Delays In Congoleum's Ch. 11 Proceedings
• Virgin Mobile Dealt Setback In Phone Patent Suit
• Ricoh Seeks Summary Judgment On Antitrust Claims
• Pioneer, Samsung Resolve Discovery Dispute
• Dr. Reddy's Wants Teva's Coreg Claims Bounced
• Grant Thornton Dropped From Tax Shelter Case